The Industri Kapital 1997 Fund has signed an agreement to sell 100% of its shares in the Elektrokoppar group to Liljedalhsbolagen. During Industri Kapital's ownership, Eelktrokoppar has strenghtened its product line as well as developed various niche products. The compnay has followed an expansion strategy through an add-on acqusition of Polish EKS Slaska, to respond to the fast growing Eastern European markets. Recently, the company has also established a presence in China.
Also backing the biotech startup were the Zürcher Kantonalbank and Greencross Medical Science Corp
Company plans to use the fresh capital to further expand, develop new features and scale up its team
EVentures, 468 Capital and HV Holtzbrinck back the round for the climate change mitigation app
Clessidra has been in negotiations for the acquisition of the Italian wine producer since February 2020